Ligand validation:6ZXV

EDO: 1,2-ETHANEDIOL

EDO is a Ligand Of Interest in 6ZXV designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZXV_EDO_B_402	40%	85%	0.197	0.908	0.48	0.27	-	-	0	0	100%	1
6ZXV_EDO_A_403	17%	79%	0.159	0.731	0.59	0.28	-	-	0	0	100%	1
6ZXV_EDO_A_402	13%	77%	0.228	0.764	0.65	0.26	-	-	0	0	100%	1
6ZXV_EDO_A_404	6%	76%	0.299	0.73	0.43	0.51	-	-	0	0	100%	1
6ZXW_EDO_G_403	14%	80%	0.303	0.853	0.71	0.14	-	-	2	0	100%	1
6ZXY_EDO_B_501	0%	79%	0.565	0.345	0.66	0.2	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1
1EB6_EDO_A_1180	100%	64%	0.041	0.986	0.62	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.